Role of gammaherpesvirus lytic replication-associated genes in the establishment
伽马疱疹病毒裂解复制相关基因在建立中的作用
基本信息
- 批准号:8018599
- 负责人:
- 金额:$ 29.49万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-02-01 至 2015-01-31
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAcuteAddressAttenuatedB-LymphocytesDataDefective VirusesDevelopmentDiseaseEpigenetic ProcessEpisomeEventGene ExpressionGenesGenomicsGoalsHIVHerpesviridaeHerpesviridae InfectionsHistone DeacetylaseHistone DeacetylationHistonesHourHumanHuman Herpesvirus 4Human Herpesvirus 8Immunocompromised HostInfectionLaboratoriesLifeLinkLyticMaintenanceMalignant - descriptorMalignant NeoplasmsMediatingMethodologyModalityModificationMolecularMusMutateMutationPatientsPhasePhysiologicalPopulations at RiskProcessProteinsRecombinantsResearchRiskRoleSatellite VirusesStagingSystemTestingTherapeuticTimeTransplant RecipientsViralViral GenesViral GenomeVirusWorkattenuationcancer typedesigndrug developmentgammaherpesvirusin vivoinfected B cellinsightlatent infectionlytic replicationmutantnovel markerpreventpublic health relevancetoolvirus episome maintenance
项目摘要
DESCRIPTION (provided by applicant): Human gammaherpesvirus infection is linked to the development of multiple types of malignancies. These viruses pose a particularly significant risk to immunocompromised patients such as those infected with HIV. Gammaherpesviruses establish stable life-long latent infection in B cells, providing a lifelong reservoir of virus that can eventually contribute to the development of malignant disease. Our long-term goal is to define the mechanisms that gammaherpesviruses use to establish latency in B cells, thereby elucidating new targets for the development of modalities to prevent gammaherpesvirus-associated malignancies. Our approach is to dissect the earliest events of latency establishment using mutant viruses in the murine gammaherpesvirus (gammaHV68, MHV68) system that are unable to undergo lytic replication. By comparing viruses that are mutated in early versus late lytic genes, we have uncovered a surprising role for lytic replication-associated gene products in the establishment of latency in B cells. We hypothesize that these key lytic gene products are critical for the induction of epigenetic modifications that are critical for retention of latent viral episomes. The goals of this proposal are to define the critical molecular events that occur in the earliest hours following B cell infection that ultimately result in stable maintenance of the viral episome during latency. Specifically, we will define the viral transcriptional and genomic events that occur during the establishment phase of B cell latency (Aim 1), we will define the specific late lytic gene that is required for the establishment of stable latency (Aim 2), and we will test the hypothesis that the crucial lytic gene induces epigenetic modifications that are critical for latency establishment in B cells. The proposed studies should provide significant new insight into the critical molecular events that occur during the earliest moments of gammaherpesvirus infection of B cells.
PUBLIC HEALTH RELEVANCE: Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus infections are linked to the development of numerous types of cancers, and pose a particularly significant risk to AIDS patients and transplant recipients. The proposed research will examine the events that occur in the earliest stages of infection in an effort to gain new insight into the means by which these viruses establish lifelong infections. This work has important implications for the development of drugs to prevent or treat virus-associated cancers.
描述(由申请人提供):人类伽马疱疹病毒感染与多种恶性肿瘤的发生有关。这些病毒对免疫功能低下的患者(例如感染艾滋病毒的患者)构成特别重大的风险。伽马疱疹病毒在 B 细胞中建立稳定的终生潜伏感染,提供终生病毒库,最终导致恶性疾病的发展。我们的长期目标是确定伽马疱疹病毒在 B 细胞中建立潜伏期的机制,从而阐明开发预防伽马疱疹病毒相关恶性肿瘤的新靶点。我们的方法是使用鼠伽马疱疹病毒(gammaHV68,MHV68)系统中无法进行裂解复制的突变病毒来剖析潜伏期建立的最早事件。通过比较早期和晚期裂解基因突变的病毒,我们发现了裂解复制相关基因产物在 B 细胞潜伏期建立中的惊人作用。我们假设这些关键的裂解基因产物对于诱导表观遗传修饰至关重要,而表观遗传修饰对于保留潜伏病毒附加体至关重要。该提案的目标是定义 B 细胞感染后最早几个小时内发生的关键分子事件,最终导致潜伏期病毒附加体的稳定维持。具体来说,我们将定义 B 细胞潜伏期建立阶段发生的病毒转录和基因组事件(目标 1),我们将定义建立稳定潜伏期所需的特定晚期裂解基因(目标 2),并且我们将测试以下假设:关键的裂解基因诱导对 B 细胞潜伏期建立至关重要的表观遗传修饰。拟议的研究应该为 B 细胞伽马疱疹病毒感染最早时刻发生的关键分子事件提供重要的新见解。
公共卫生相关性:爱泼斯坦-巴尔病毒和卡波西肉瘤相关疱疹病毒感染与多种癌症的发生有关,并对艾滋病患者和移植受者构成特别重大的风险。拟议的研究将检查感染最早阶段发生的事件,以便对这些病毒建立终身感染的方式有新的了解。这项工作对于开发预防或治疗病毒相关癌症的药物具有重要意义。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Scott A. Tibbetts其他文献
Scott A. Tibbetts的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Scott A. Tibbetts', 18)}}的其他基金
"Project 3" Defining the in vivo function of ncRNAs during MHV68 latency and lymphomagenesis
“项目 3”定义 ncRNA 在 MHV68 潜伏期和淋巴瘤发生过程中的体内功能
- 批准号:
10865790 - 财政年份:2023
- 资助金额:
$ 29.49万 - 项目类别:
Gammaherpesvirus miRNA suppression of EWSR1 in GC B cell infection and lymphomagenesis
伽马疱疹病毒 miRNA 对 GC B 细胞感染和淋巴瘤发生中 EWSR1 的抑制
- 批准号:
10276889 - 财政年份:2021
- 资助金额:
$ 29.49万 - 项目类别:
Gammaherpesvirus miRNA suppression of EWSR1 in GC B cell infection and lymphomagenesis
伽马疱疹病毒 miRNA 对 GC B 细胞感染和淋巴瘤发生中 EWSR1 的抑制
- 批准号:
10458112 - 财政年份:2021
- 资助金额:
$ 29.49万 - 项目类别:
Gammaherpesvirus miRNA suppression of EWSR1 in GC B cell infection and lymphomagenesis
伽马疱疹病毒 miRNA 对 GC B 细胞感染和淋巴瘤发生中 EWSR1 的抑制
- 批准号:
10665619 - 财政年份:2021
- 资助金额:
$ 29.49万 - 项目类别:
"Core D" Clinical Sample and Tumorigenesis Core
“Core D”临床样本和肿瘤发生核心
- 批准号:
10403021 - 财政年份:2017
- 资助金额:
$ 29.49万 - 项目类别:
"Core D" Clinical Sample and Tumorigenesis Core
“Core D”临床样本和肿瘤发生核心
- 批准号:
10646260 - 财政年份:2017
- 资助金额:
$ 29.49万 - 项目类别:
"Project 3" Defining the in vivo function of ncRNAs during MHV68 latency and lymphomagenesis
“项目 3”定义 ncRNA 在 MHV68 潜伏期和淋巴瘤发生过程中的体内功能
- 批准号:
10403017 - 财政年份:2017
- 资助金额:
$ 29.49万 - 项目类别:
"Project 3" Defining the in vivo function of ncRNAs during MHV68 latency and lymphomagenesis
“项目 3”定义 ncRNA 在 MHV68 潜伏期和淋巴瘤发生过程中的体内功能
- 批准号:
10646240 - 财政年份:2017
- 资助金额:
$ 29.49万 - 项目类别:
Role of MHV68 miRNAs in latencyand pathogenesis
MHV68 miRNA 在潜伏期和发病机制中的作用
- 批准号:
8846933 - 财政年份:2015
- 资助金额:
$ 29.49万 - 项目类别:
Role of MHV68 miRNAs in latencyand pathogenesis
MHV68 miRNA 在潜伏期和发病机制中的作用
- 批准号:
9195696 - 财政年份:2015
- 资助金额:
$ 29.49万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 29.49万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 29.49万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 29.49万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 29.49万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 29.49万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 29.49万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 29.49万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 29.49万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 29.49万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 29.49万 - 项目类别:
Standard Grant